.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Deloitte
Citi
Fuji
Healthtrust
McKinsey
Accenture
Cantor Fitzgerald
Medtronic

Generated: December 18, 2017

DrugPatentWatch Database Preview

THALLOUS CHLORIDE TL 201 Drug Profile

« Back to Dashboard

When do Thallous Chloride Tl 201 patents expire, and what generic alternatives are available?

Thallous Chloride Tl 201 is a drug marketed by Bracco, Ge Healthcare, Lantheus Medcl, Mallinkrodt Nuclear, and Trace Life. and is included in six NDAs.

The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.
Drug patent expirations by year for THALLOUS CHLORIDE TL 201

Pharmacology for THALLOUS CHLORIDE TL 201

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
BraccoTHALLOUS CHLORIDE TL 201thallous chloride tl-201INJECTABLE;INJECTION018548-001Dec 30, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt NuclearTHALLOUS CHLORIDE TL 201thallous chloride tl-201INJECTABLE;INTRAVENOUS077698-001Nov 9, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt NuclearTHALLOUS CHLORIDE TL 201thallous chloride tl-201INJECTABLE;INJECTION018150-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Ge HealthcareTHALLOUS CHLORIDE TL 201thallous chloride tl-201INJECTABLE;INJECTION018110-002Feb 27, 1996APRXYesYes► Subscribe► Subscribe► Subscribe
Lantheus MedclTHALLOUS CHLORIDE TL 201thallous chloride tl-201INJECTABLE;INJECTION017806-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Lantheus MedclTHALLOUS CHLORIDE TL 201thallous chloride tl-201INJECTABLE;INTRAVENOUS017806-002Oct 9, 1998APRXYesYes► Subscribe► Subscribe► Subscribe
Trace LifeTHALLOUS CHLORIDE TL 201thallous chloride tl-201INJECTABLE;INJECTION075569-001Nov 21, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Merck
Harvard Business School
UBS
McKesson
Express Scripts
Argus Health
Farmers Insurance
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot